TudorSN inhibitors belong to a specific chemical class that plays a crucial role in the realm of molecular biology and cellular processes. These inhibitors are designed to target TudorSN, a protein that belongs to the Tudor domain-containing family. The Tudor domain is a conserved protein motif found in various organisms and is known for its ability to recognize and bind to methylated proteins and nucleic acids. TudorSN, specifically, is involved in the recognition and binding of methylated arginine residues on proteins, playing a vital role in processes like RNA metabolism, transcriptional regulation, and signal transduction.
The chemical class of TudorSN inhibitors comprises small molecules or compounds that are strategically designed to disrupt the interaction between TudorSN and its methylated substrates. These inhibitors typically work by binding to TudorSN and its binding to methylated targets, thus interfering with the normal cellular functions associated with TudorSN. By doing so, TudorSN inhibitors have the potential to impact various cellular processes where TudorSN is involved, potentially leading to downstream effects on gene expression, RNA processing, and other essential biological functions. The development and study of TudorSN inhibitors hold significant promise in advancing our understanding of the molecular mechanisms underlying epigenetic regulation and methylated protein interactions, shedding light on fundamental cellular processes that are essential for the proper functioning of living organisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is a c-Raf kinase inhibitor that influences MAPK/ERK pathways, potentially affecting downstream proteins such as TudorSN by altering transcription regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which can influence cellular processes including apoptosis and transcription where TudorSN may play a role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can affect various signaling pathways, potentially impacting mechanisms where TudorSN is involved. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that prevents the activation of MAPK/ERK pathway, which can indirectly affect TudorSN activity in the cell. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor, which may alter stress responses and cytokine production, thereby potentially influencing TudorSN-related pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can affect protein synthesis and autophagy, processes that could involve TudorSN. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can disrupt signaling pathways and thus indirectly inhibit the function of TudorSN. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine is an Akt inhibitor that can disrupt cell survival and growth signals, potentially impacting TudorSN through these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which can affect the MAPK/ERK pathway, potentially altering the activity of TudorSN. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Dorsomorphin is an inhibitor of AMPK, which can influence cellular energy homeostasis and potentially affect TudorSN-related processes. | ||||||